Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antipsychotic Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03451734
What this trial is testing

Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients

Who this might be right for
SchizophreniaMetabolic Syndrome
Central South University 2,000
Large-scale testing (Phase 3)Study completedNCT06067984
What this trial is testing

An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia

Who this might be right for
SchizophreniaNegative Symptoms in Schizophrenia
Click Therapeutics, Inc. 73
Post-approval studies (Phase 4)Study completedNCT00304616
What this trial is testing

SWitching to Abilify Trial (SWAT)

Who this might be right for
Schizophrenia
Korea Otsuka Pharmaceutical Co., Ltd. 500
Large-scale testing (Phase 3)Study completedNCT00246285
What this trial is testing

The Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 381
Post-approval studies (Phase 4)UnknownNCT02040883
What this trial is testing

Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia

Who this might be right for
Schizophrenia
Qingyun Yin 100
Not applicableStudy completedNCT01181960
What this trial is testing

Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

Who this might be right for
SchizophreniaBipolar Disorder
Janssen Scientific Affairs, LLC 1,066
Large-scale testing (Phase 3)UnknownNCT01320982
What this trial is testing

Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sheba Medical Center 400
Not applicableStudy completedNCT06326840
What this trial is testing

Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment

Who this might be right for
Metabolic DisturbanceHyperprolactinemiaSchizophrenia
Taipei Medical University Hospital 42
Large-scale testing (Phase 3)Study completedNCT00249223
What this trial is testing

A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen Pharmaceutica N.V., Belgium 641
Large-scale testing (Phase 3)Study completedNCT01235520
What this trial is testing

RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 595
Large-scale testing (Phase 3)Study completedNCT00488319
What this trial is testing

Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

Who this might be right for
SchizophreniaSchizophrenic DisordersPsychotic Disorders+1 more
Janssen Research & Development, LLC 400
Not applicableStudy completedNCT02029989
What this trial is testing

Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness

Who this might be right for
HyperlipidemiaDiabetesHypertension
University of Minnesota 121
Not applicableStudy completedNCT00406718
What this trial is testing

Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
The University of Texas Health Science Center at San Antonio 197
Not applicableWithdrawnNCT05939765
What this trial is testing

Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study.

Who this might be right for
Schizophrenia
Psychiatric University Hospital, Zurich
Post-approval studies (Phase 4)Ended earlyNCT00649220
What this trial is testing

Memantine and Antipsychotics Use

Who this might be right for
Alzheimer's Disease
Merz Pharmaceuticals GmbH 19
Large-scale testing (Phase 3)UnknownNCT03284294
What this trial is testing

Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia

Who this might be right for
Schizophrenia
Universitas Padjadjaran 40
Not applicableUnknownNCT03192631
What this trial is testing

Financial Incentives to Improve Acceptance of Antipsychotic Injections

Who this might be right for
SchizophreniaSchizo Affective DisorderBipolar I Disorder
Focus Community Mental Health Team 20
Not applicableUnknownNCT02205437
What this trial is testing

Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia

Who this might be right for
Schizophrenia
Fundación Marques de Valdecilla 200
Post-approval studies (Phase 4)Looking for participantsNCT07483294
What this trial is testing

Cerebellum-based Imaging Neural Markers for Antipsychotic Response

Who this might be right for
Psychosis; Acute
Northwell Health 120
Post-approval studies (Phase 4)UnknownNCT00182494
What this trial is testing

Diabetes Prevention Program in Schizophrenia [DPPS]

Who this might be right for
Diabetes MellitusSchizophrenia
Hamilton Health Sciences Corporation 200
Next Page